• Tubastatin A Reduces Myocardial Injury via Pyroptosis and Ne

  2026-05-29

  The referenced study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, mitigates post-resuscitation myocardial damage in a porcine cardiac arrest model by suppressing GSDME-mediated pyroptosis and MLKL-mediated necroptosis. These findings highlight the potential of HDAC6 inhibition as a targeted approach to limit cardiac injury following ischemia-reperfusion events.

• Pharmacokinetics of Corydalis Alkaloids in MASH: Variability

  2026-05-28

  This study systematically characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in a high-fat, high-cholesterol diet mouse model. By revealing the influence of disease state on drug metabolism and transporter systems, the research provides valuable guidance for optimizing dosing strategies in MASLD/MASH therapy.

• Technical Use of Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-28

  The Hoechst 33342/PI Double Staining Kit enables clear, fluorescence-based discrimination between viable, apoptotic, and necrotic cells by assessing chromatin condensation and membrane integrity. Its application is best suited for non-clinical, basic research in cell death analysis using fluorescence microscopy. This kit is not appropriate for diagnostic or therapeutic workflows.

• ATRX-Deficient Glioma: Sensitivity to RTK and PDGFR Inhibito

  2026-05-27

  The referenced study demonstrates that high-grade glioma cells lacking ATRX exhibit elevated sensitivity to multi-targeted RTK and PDGFR inhibitors. These findings highlight the importance of ATRX status in designing targeted therapies and clinical trial analyses for aggressive gliomas.

• Spermine: Endogenous Polyamine for Ion Channel Assays

  2026-05-27

  Spermine, a high-purity endogenous polyamine from APExBIO, redefines experimental control in ion channel and cellular metabolism studies through its potent inward rectifier potassium channel modulation. Leverage actionable workflows, troubleshooting guidance, and insights from recent nuclear envelope research to optimize your cell-based assays.

• Applied Cyclosporin A: Immunosuppression and Assay Mastery

  2026-05-26

  Cyclosporin A uniquely enables precise T-cell inhibition and mitochondrial regulation, making it indispensable for immunology, transplantation, and mechanistic research. This article delivers stepwise protocols, troubleshooting, and expert guidance for leveraging APExBIO's Cyclosporin in advanced experimental workflows.

• Hoechst 33258 in Tumor Microenvironment pH and DNA Staining

  2026-05-26

  Explore how Hoechst 33258, a bis-benzimide DNA stain, enables advanced, quantitative mapping of DNA integrity and pH-dependent cellular states in live and fixed cells. This article uniquely connects spectral and cell permeability properties to tumor microenvironment research, offering insights beyond standard staining protocols.

• Practical Use of 0.4% Trypan Blue Solution in Cell Viability

  2026-05-25

  0.4% Trypan Blue Solution is a standardized azo dye for cell staining, essential for distinguishing live and dead cells in research workflows. It provides a direct, rapid assessment for cell viability measurement and cell counting, but should not be used for diagnostic or medical purposes.

• Entinostat (MS-275): Strategic HDAC1/3 Inhibition in Oncolog

  2026-05-25

  Entinostat (MS-275, SNDX-275) exemplifies targeted epigenetic modulation, offering translational researchers a robust tool for interrogating and inhibiting cancer cell proliferation. This thought-leadership article integrates mechanistic insight, in vitro evaluation strategies, and clinical guidance, anchoring Entinostat’s role in future oncology workflows and bridging the divide between discovery science and therapeutic impact.

• Difloxacin HCl: Advanced Antimicrobial and MDR Reversal Prot

  2026-05-24

  Difloxacin HCl stands apart as a quinolone antimicrobial antibiotic, empowering both robust antimicrobial susceptibility testing and innovative research on multidrug resistance reversal. This article delivers actionable, protocol-driven insights for optimizing microbiology and oncology workflows, with troubleshooting tips grounded in recent mechanistic advances.

• PKM2 inhibitor (compound 3k): Applied Workflows & Optimizati

  2026-05-23

  PKM2 inhibitor (compound 3k) from APExBIO enables targeted disruption of glycolytic metabolism in cancer and inflammation models, with robust selectivity and in vivo validation. This guide provides actionable protocol enhancements, troubleshooting insights, and workflow adaptations for researchers leveraging this potent pyruvate kinase M2 inhibitor.

• Stem Cell-Derived Intestinal Organoids for Pharmacokinetic M

  2026-05-22

  This study establishes a direct 3D culture protocol to generate human pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) suitable for long-term propagation and pharmacokinetic studies. The work addresses key limitations of traditional models and provides a scalable, human-relevant platform for evaluating drug absorption and metabolism in vitro.

• Mecamylamine Hydrochloride: Precision Dissection of nAChR Ci

  2026-05-22

  Explore Mecamylamine hydrochloride as a non-competitive nAChR antagonist for advanced neuropsychiatric disorder research. This article uniquely bridges mechanistic insight with practical assay protocols, highlighting implications for gut-brain cholinergic signaling studies.

• 0.4% Trypan Blue Solution: Technical Guidance for Cell Viabi

  2026-05-21

  0.4% Trypan Blue Solution is an azo dye reagent for distinguishing live from dead cells in cell culture workflows. It addresses the need for reliable cell viability measurement during cell counting, cytotoxicity assays, and viability-based sorting. This product is suitable for research applications but should not be used for diagnostic or clinical purposes.

• Deep Learning Reveals Cardiotoxicity in iPSC-CM High-Content

  2026-05-21

  This study demonstrates the integration of deep learning with high-content imaging of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to rapidly identify drug-induced cardiotoxicity. The findings underscore the potential of scalable, phenotypic screening approaches for early de-risking in cardiac drug discovery.

483 records 12/33 page Previous Next First page 上5页 1112131415 下5页 Last page